Perspective Therapeutics (CATX) Return on Sales (2010 - 2023)

Perspective Therapeutics has disclosed Return on Sales across 14 years of filings, most recently posting 0.01% for Q4 2023.

• Return on Sales for Q4 2023 came in at 0.01%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was 0.15% (changed N/A YoY), and the FY2023 annual result was 0.06%, changed N/A from the prior year.
• Return on Sales came in at 0.01% for Q4 2023 at Perspective Therapeutics, up from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q4 2023 to a low of 0.02% in Q3 2022.
• The 5-year median for Return on Sales is 0.0% (2022), against an average of 0.0%.
• Across the five-year window, Return on Sales fell 1 bps in 2021 and grew 2 bps in 2023, its largest moves.
• Perspective Therapeutics' Return on Sales stood at 0.0% in 2019, then rose by 10 bps to 0.0% in 2020, then tumbled by 55 bps to 0.01% in 2021, then plunged by 316 bps to 0.02% in 2022, then soared by 145 bps to 0.01% in 2023.
• The last three Return on Sales figures came in at 0.01% (Q4 2023), 0.0% (Q3 2023), and 0.01% (Q2 2023), per Business Quant data.